Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3305677 in Healthy Subjects

Next Previous
Trial Profile

A Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3305677 in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Aug 2018

At a glance

  • Drugs LY 3305677 (Primary)
  • Indications Unspecified
  • Focus Adverse reactions
  • Sponsors Eli Lilly

    • Most Recent Events

    • 15 Aug 2018 Status changed from active, no longer recruiting to completed.
    • 10 May 2018 Status changed from recruiting to active, no longer recruiting.
    • 01 Nov 2017 Planned End Date changed from 1 Jun 2018 to 1 Aug 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top